INDEMNIFICATION AGREEMENTIndemnification Agreement • November 13th, 2013 • Kindred Biosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 13th, 2013 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is made and entered into as of _________________, 2013, by and between Kindred Biosciences, Inc. (the “Company”) and ____________________ (the “Indemnitee”).
KINDRED BIOSCIENCES INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • November 13th, 2013 • Kindred Biosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 13th, 2013 Company Industry JurisdictionThis Investors’ Rights Agreement (this “Agreement”) is made as of October 23, 2012 by and among Kindred Biosciences, Inc., a Delaware corporation (the “Company”) and the persons and entities (each, an “Investor” and collectively, the “Investors”) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • November 13th, 2013 • Kindred Biosciences, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 13th, 2013 Company IndustryThis Amendment No. 1 to Employment Agreement (this “Amendment”) is made as of November 11, by and between Kindred Biosciences, Inc., a Delaware corporation (the “Company”), and Denise Bevers, an individual and resident of the State of California (the “Executive”), with reference to the following facts:
KINDRED BIOSCIENCES INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • November 13th, 2013 • Kindred Biosciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 13th, 2013 Company Industry JurisdictionThis Investors’ Rights Agreement (this “Agreement”) is made as of June 1, 2013 by and among Kindred Biosciences, Inc., a Delaware corporation (the “Company”) and the persons and entities (each, an “Investor” and collectively, the “Investors”) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENTEmployment Agreement • November 13th, 2013 • Kindred Biosciences, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 13th, 2013 Company IndustryThis Amendment No. 2 to Employment Agreement (this “Amendment”) is made as of November 11, by and between Kindred Biosciences, Inc., a Delaware corporation (the “Company”), and Richard Chin, an individual and resident of the State of California (the “Executive”), with reference to the following facts: